COVID-19: Lessons from Norway tragedy must be considered in vaccine rollout planning in least developed/developing countries

All governments, regulatory authorities, and vaccine-related committees are under tremendous pressure to roll out vaccines to safeguard the people against COVID-19. To be noted that all COVID-19 vaccines have been developed hurriedly, some with new technologies being used on humans for the first time ever. Most clinical trials did not include elderly patients with comorbidities, hence a careful and logical rollout planning, especially for elderly people, is necessary.

Automated summary

Governments, regulatory authorities, and vaccine-related committees are facing immense pressure to roll out COVID-19 vaccines quickly to protect people. It is important to note that these vaccines are developed hastily with some using new technologies on humans for the first time, and most clinical trials not including elderly patients with comorbidities. Therefore, careful and logical rollout planning, especially for the elderly, is necessary.